In this week's episode, we explore the quest for a therapy that not only alleviates symptoms of osteoarthritis but also addresses the underlying disease process. Host Professor David Hunter is joined by Chris Knight and Dr Sandeep Basnet from Formation Bio to discuss the complexities and breakthroughs in developing disease-modifying osteoarthritis drugs (DMOADs). They dive into the challenges of clinical trials, the high stakes of drug development, and the promising future of AI in revolutionising this field. Tune in to learn how close we are to seeing these game-changing therapies become a reality and what it could mean for millions living with osteoarthritis. RESOURCES Formation Bio: https://www.formation.bio/ CONNECT WITH US Twitter/X: @ProfDavidHunter @jointactionorgInstagram: @ProfDavidHunterEmail: [email protected] Hosted on Acast. See acast.com/privacy for more information.